The immunologic character of acquired inhibitors of antihemophilic globulin (factor 8) and the kinetics of their interaction with factor 8.

scientific article

The immunologic character of acquired inhibitors of antihemophilic globulin (factor 8) and the kinetics of their interaction with factor 8. is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1172/JCI105517
P932PMC publication ID297033
P698PubMed publication ID6018754

P2093author name stringShapiro SS
P2860cites workProtein measurement with the Folin phenol reagentQ20900776
PLASMA CELL MYELOMA: GAMMA GLOBULIN SYNTHESIS AND STRUCTURE. A REVIEW OF BIOCHEMICAL AND CLINICAL DATA, WITH THE DESCRIPTION OF A NEWLY-RECOGNIZED AND RELATED SYNDROME, "H-GAMMA-2-CHAIN (FRANKLIN'S) DISEASEQ30863646
A circulating anticoagulant in gamma-1A-multiple myeloma: its modification by penicillinQ33960970
Effect of antihemophilic factor on one-stage clotting tests; a presumptive test for hemophilia and a simple one-stage antihemophilic factor assy procedureQ34232161
The kaolin clotting time; a rapid one-stage method for diagnosis of coagulation defectsQ34244473
Circulating anticoagulants: a study of 40 cases and a review of the literature.Q35323162
Acquired hemophilia due to a circulating anticoagulant. Report of two cases, with review of the literatureQ35372557
LOCALIZATION OF ANTIBODIES IN GROUP I AND GROUP II γ-GLOBULINSQ36266392
A CIRCULATING ANTICOAGULANT INHIBITING ANTIHAEMOPHILIC GLOBULINQ36509504
ELECTROPHORETIC ISOLATION OF A CIRCULATING ANTICOAGULANT.Q40976231
Physical properties of the red cell agglutinins in acquired hemolytic anemiaQ42732311
A clinical and experimental study of acquired inhibitors to factor 8Q45859055
Hemophilia-like disease following pregnancy with transplacental transfer of an acquired circulating anticoagulantQ45865628
A method for the study of antihaemophilic globulin inhibitors with reference to six casesQ45866988
Studies on the nature of the circulating anticoagulant directed against antihemophilic factor: with notes on an assay for anthemophilic factorQ45867143
Assay of plasma thromboplastin antecedent (PTA) with artificially depleted normal plasma.Q45867368
A PATIENT WITH AN UNUSUAL CIRCULATING ANTICOAGULANTQ45868108
A brain extract as a substitute for platelet suspensions in the thromboplastin generation test.Q51340333
Exclusive occurrence of K chains in isolated cold haemagglutinins.Q54621043
Haemophilia-like disease due to an auto-antibody.Q55456080
A cold agglutinin of the IgA classQ70064947
A clinical and laboratory study of a patient with an unusual factor VIII inhibitorQ72801528
Precipitation and inhibition of carboxypeptidase by specific antiseraQ73065866
[A micro-method of immuno-electrophoresis]Q73825157
The kinetics of the reactions between antibodies to the 2,4 dinitrophenyl group and specific haptensQ76476776
ANTIBODY ACTIVITY IN SIX CLASSES OF HUMAN IMMUNOGLOBULINSQ76608625
TWO TYPES OF 6.6 S GAMMA-GLOBULINS, BETA-2A-GLOBULINS AND 18 S GAMMA 1-MACROGLOBULINS IN NORMAL SERUM AND GAMMA-MICROGLOBULINS IN NORMAL URINEQ76614440
STRUCTURAL BASIS FOR THE DIFFERENCES BETWEEN TYPE I AND TYPE II HUMAN GAMMA-GLOBULIN MOLECULESQ76614443
ANTI-FACTOR VIII CIRCULATING ANTICOAGULANTS DURING HEMOPHILIA A. (NATURE AND MECHANISM OF ACTION)Q76655432
ACQUIRED HEMOPHILIA CAUSED BY A CIRCULATING ANTICOAGULANTQ76795683
ANTIGENIC HETEROGENEITY OF HUMAN RH ANTIBODIES, RHEUMATOID FACTORS, AND COLD AGGLUTININSQ76846464
CIRCULATING ANTICOAGULANT AGAINST FACTOR 8 COEXISTENT WITH SOME IMMUNOLOGICAL REACTIONS IN A FEMALEQ76916210
STRUCTURAL STUDIES OF THE IMMUNOGLOBULINS. I. THE TRYPTIC PEPTIDES OF BENCE-JONES PROTEINSQ78332197
Acquired Inhibitor of Blood CoagulationQ78979597
Kinetics of the inhibition of Cypridina luciferase by specific antibodyQ79292442
An antihaemophilic globulin (factor VIII) inhibitor: purification, characterization and reaction kineticsQ79440668
P433issue2
P407language of work or nameEnglishQ1860
P304page(s)147-156
P577publication date1967-02-01
P1433published inJournal of Clinical InvestigationQ3186904
P1476titleThe immunologic character of acquired inhibitors of antihemophilic globulin (factor 8) and the kinetics of their interaction with factor 8.
P478volume46